Cargando…
Inhibitory effect of anti-Scg3 on corneal neovascularization: a preliminary study
BACKGROUND: Corneal neovascularization (CNV) is an important disease that causes blindness. Secretogranin III (Scg3) has emerged as a new influencing factor of neovascularization. This study analyzed the Scg3 antibody’s inhibitory effect on CNV and and explored its preliminary mechanism. METHODS: Hu...
Autores principales: | Jin, He, Yang, Binbin, Jiang, Dongdong, Ding, Zhixiang, Xiong, Yu, Zeng, Xinsheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9703748/ https://www.ncbi.nlm.nih.gov/pubmed/36443679 http://dx.doi.org/10.1186/s12886-022-02690-7 |
Ejemplares similares
-
Anti-Scg3 Gene Therapy to Treat Choroidal Neovascularization in Mice
por: Huang, Chengchi, et al.
Publicado: (2023) -
Association of four gene polymorphisms in Chinese Guangxi population with diabetic retinopathy in type 2 diabetic patients
por: Jin, He, et al.
Publicado: (2021) -
Optimal Efficacy and Safety of Humanized Anti-Scg3 Antibody to Alleviate Oxygen-Induced Retinopathy
por: He, Ye, et al.
Publicado: (2021) -
Mutations in SCG10 Are Not Involved in Hirschsprung Disease
por: Alves, Maria M. M., et al.
Publicado: (2010) -
Inhibitory effects of polysaccharide extract from Spirulina platensis on corneal neovascularization
por: Yang, Lingling, et al.
Publicado: (2009)